结节病患者的急诊住院原因与预后
本研究回顾性分析2017至2020年间154例急诊住院的结节病患者,主要入院原因为下呼吸道感染(21%)、结节病急性加重(11%)、疑似心脏结节病(8.4%)和神经结节病(7.7%)。院内死亡率为3.9%,住院后2年无移植生存率为86.8%(95%CI 81.4-92.5)。Charlson合并症指数、肺动脉高压和住院期间氧疗与更差的无移植生存相关。
要点
- 下呼吸道感染是结节病患者急诊住院的首位原因(21%)。
- 合并症负担、肺动脉高压和需氧疗提示预后更差。
- 急诊住院结节病患者整体死亡率较高,需关注呼吸衰竭严重程度。
核心结论
- 急诊住院的结节病患者整体死亡率较高。
- 合并症和呼吸衰竭严重程度(以需氧疗反映)是重要预后决定因素。
研究设计与样本
- 回顾性单中心研究,纳入2017年1月1日至2020年7月7日期间急诊科或ICU住院、或经电话咨询/门诊后非计划住院的结节病患者,共154例。
主要发现
- 154例中14例(9%)需ICU治疗;男性81例,中位年龄55.0岁(IQR 44.0-67.0)。
- 结节病首发起病者20例(14%);主要入院原因:下呼吸道感染32例(21%)、结节病急性肺加重17例(11%)、疑似心脏结节病13例(8.4%)、神经结节病12例(7.7%)。
- 中位住院时间6天(IQR 3.00-10.0);院内死亡率3.9%;住院后2年无移植生存率86.8%(95%CI 81.4-92.5)。
临床怎么用
- 对急诊住院的结节病患者,应评估合并症负担、肺动脉高压及氧疗需求以识别高危患者。
- 下呼吸道感染是常见入院原因,需注意鉴别结节病急性加重。
局限性
- 回顾性单中心设计可能限制结果的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcoidosis is an idiopathic systemic granulomatosis whose evolution is self-limiting in most cases. However, it can progress to organ damage that menaces the vital or functional prognosis of patients. Sarcoidosis itself, but also its comorbidities, can pose a threat to the patient, require rapid initiation of treatment, and justify emergency hospitalization. RESEARCH QUESTION: What are the reasons and prognosis of patients with sarcoidosis hospitalized in emergency? STUDY DESIGN AND METHODS: The objectives of our study were to describe the causes of admission for and to identify predictors of mortality in patients with sarcoidosis hospitalized in emergency. This is a retrospective monocentric study. We included patients hospitalized after a stay in the ED or ICU, or requiring an unscheduled hospitalization after telephone advice or a consultation, between January 1, 2017, and July 7, 2020. RESULTS: We identified 154 patients with sarcoidosis hospitalized in emergency, among which 14 (9%) required the ICU. There were 81 male patients, with a median age of 55.0 years (interquartile range, 44.0-67.0). Sarcoidosis was inaugural in 20 patients (14%). The primary reason for hospitalization was lower respiratory infections in 32 patients (21%), followed by acute pulmonary exacerbation of sarcoidosis in 17 (11%), suspected cardiac sarcoidosis in 13 (8.4%), and neurosarcoidosis in 12 (7.7%). The median length of stay was 6 days (interquartile range, 3.00-10.0). In-hospital mortality rate was 3.9%. The 2-year transplantation-free survival after hospitalization was 86.8% (95% CI, 81.4-92.5). The factors associated with a worse transplantation-free survival were Charlson Comorbidity Index score (hazard ratio [HR], 1.29; 95% CI, 1.04-1.61; P = .021), pulmonary hypertension (HR, 2.53; 95% CI, 1.10-5.83; P = .029), and oxygen therapy during hospitalization (HR, 4.18; 95% CI, 1.55-11.29; P = .005). INTERPRETATION: Our findings indicate that the overall mortality of patients with sarcoidosis hospitalized in emergency was high. The presence of comorbidities and the severity of respiratory failure, as reflected by oxygen requirement, are important prognostic determinants.
引用
- Gazengel P, Hindre R, Jeny F, et al. Sarcoidosis and Emergency Hospitalization. Chest. 2024. PMID: 39209060. doi:10.1016/j.chest.2024.06.3839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。